NM_024835.5:c.374C>T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_024835.5(GGNBP2):c.374C>T(p.Thr125Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,613,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024835.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GGNBP2 | ENST00000613102.5 | c.374C>T | p.Thr125Ile | missense_variant | Exon 4 of 14 | 1 | NM_024835.5 | ENSP00000478220.1 | ||
| GGNBP2 | ENST00000616019.1 | c.374C>T | p.Thr125Ile | missense_variant | Exon 3 of 4 | 2 | ENSP00000484094.1 | |||
| GGNBP2 | ENST00000617860.4 | n.659C>T | non_coding_transcript_exon_variant | Exon 4 of 8 | 2 | |||||
| GGNBP2 | ENST00000618837.4 | n.646C>T | non_coding_transcript_exon_variant | Exon 4 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251470 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461666Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727152 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74294 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.374C>T (p.T125I) alteration is located in exon 4 (coding exon 3) of the GGNBP2 gene. This alteration results from a C to T substitution at nucleotide position 374, causing the threonine (T) at amino acid position 125 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at